neurodegeneration therapies (Vical)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameneurodegeneration therapies (Vical)
Drug Alias Nameneurodegeneration therapies (Vical/Aventis)
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFresh Tracks Therapeutics IncRhone Poulenc Rorer Sa
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A